The big picture: AARP Inc. has significantly ramped up its lobbying efforts in Washington, reporting $6.63 million spent on in-house lobbying during Q1 2025 — an 18.82% jump from the previous quarter and well above its historical average of $3.75 million per quarter.

Why it matters: The senior advocacy giant is positioning itself as a major player early in the new congressional session, focusing on legislation affecting healthcare costs, retirement security, caregiving support, and fraud protection for older Americans.

Behind the lobbying: AARP’s advocacy is managed by seasoned veterans, including Debra Alvarez and David M. Certner, who have been lobbying for the organization since at least 2003 (according to Legis1 LDA records). The team leverages significant government experience through lobbyists like:

  • Rhonda S. Richards, former Staff Director on Aging for the Senate HELP Committee
  • Holly L. Biglow, former Scheduler on the House Ways and Means Committee
  • Molly Clark Flynt-Barr, previously with the Senate Judiciary Committee

Key legislation targeted:

  • Healthcare reform: Multiple bills aimed at lowering prescription drug costs and regulating Pharmacy Benefit Managers (S. 1096, S. 1095, S. 1040)
  • Caregiver support: Tax credits for family caregivers (S. 925/H.R. 2036, H.R. 138) and the Lifespan Respite Care Reauthorization Act (H.R. 2560/S. 830)
  • Retirement security: The WISH Act (H.R. 2082), Women’s Retirement Protection Act (H.R. 2023/S. 988), and SSI Savings Penalty Elimination Act (S. 1234/H.R. 2540)
  • Consumer protection: Legislation addressing AI-powered robocalls (H.R. 1027), crypto ATM fraud (S. 710), and emergency communication systems

The competitive landscape: AARP’s broad agenda puts it in direct engagement with numerous stakeholders:

  • Healthcare industry: Pharmaceutical companies (Merck, Pfizer, Amgen), medical associations, and insurance providers are actively lobbying on the same drug pricing bills
  • Financial services: Insurance companies, retirement businesses, and consumer advocates are engaging on retirement and tax legislation
  • Technology sector: Telecommunications companies and tech firms have interests in the consumer protection measures AARP supports

Between the lines: The timing and scale of AARP’s lobbying surge suggest a strategic effort to influence early policy discussions in key committees, particularly on drug pricing reforms that have advanced through the Senate Judiciary Committee and are now on the Senate calendar for potential floor action.

The bottom line: With nearly 38 million members nationwide, AARP’s aggressive lobbying push signals a determined campaign to shape legislation affecting older Americans, creating both challenges and potential alliance opportunities for other organizations with overlapping interests in healthcare, retirement, and consumer protection policy.